Close Menu

NEW YORK (GenomeWeb) – A years-long legal battle between Genmark Diagnostics and ViroNovative has been settled, putting an end to a dispute over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's intellectual property related to the detection of human metapneumovirus.

Rob Posthumus, ViroNovative's legal counsel, told GenomeWeb that the companies have signed an agreement, under which ViroNovative licensed to Genmark the IP at the center of the row. They also have agreed to dismiss lawsuits filed against each other. He declined further comment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.